Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:270-271
doi: 10.1161/01.ATV.0000154484.58485.24
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schatteman, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schatteman, G.
Related Collections
Right arrow Angiogenesis
Right arrow Cell biology/structural biology
Right arrow Chronic ischemic heart disease
Right arrow Other Vascular biology
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:270.)
© 2005 American Heart Association, Inc.


Editorials

Are Circulating CD133+ Cells Biomarkers of Vascular Disease?

Gina Schatteman

From the Department of Exercise Science, University of Iowa, Iowa City.

Correspondence to Gina Schatteman, 406 Field House, Department of Exercise Science, University of Iowa, Iowa City, IA 52242-1111. E-mail gina-schatteman@uiowa.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Single cell bone marrow transplantation leaves no doubt as to the ability of bone marrow cells to differentiate and integrate into the endothelium, though the physiological significance of this remains controversial. Reported rates of bone marrow cell integration into the endothelium after injury vary widely, ranging from almost no cells to large percentages. Bone marrow cell maintenance of the quiescent (ie, nongrowing) vasculature has been less well studied, but at least one mouse study suggests it could be significant.1 Whether or not large numbers of circulating cells integrate into the vessel wall, a consensus seems to be emerging that circulating bone marrow–derived cells can promote vascular growth. Exactly how this is accomplished is not clear, though it is presumably due to release of proangiogenic factors.

See page 296

Mobilization of various circulating endothelial cell progenitor (CEP)–containing populations correlates with increased vascularization in tissues undergoing neovascularization, and vascular trauma including burns, coronary artery bypass graft, and myocardial infarct all mobilize CEPs.2–6 In light of these findings, the loss or dysfunction of CEPs could impact on vascular health. Hence, over the past several years a number of studies have begun to examine whether there is a relationship between CEP function and vascular disease. Of course, to do this, one must define a CEP. Therein lies the rub. No consensus has been reached as to what constitutes a CEP, and each laboratory seems to use a different definition. Generally speaking, CEP-containing populations that have been studied fall into two broad categories: cells related . . . [Full Text of this Article]


Related Article:

Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease
Tiffany M. Powell, Jonathan D. Paul, Jonathan M. Hill, Michael Thompson, Moshe Benjamin, Maria Rodrigo, J. Philip McCoy, Elizabeth J. Read, Hanh M. Khuu, Susan F. Leitman, Toren Finkel, and Richard O. Cannon, III
Arterioscler Thromb Vasc Biol 2005 25: 296-301. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Dotsenko and M. Jahangiri
Endogenous stem cells in patients undergoing coronary artery bypass graft surgery
Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. P. Fadini, S. V. de Kreutzenberg, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, and A. Avogaro
Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk
Eur. Heart J., September 2, 2006; 27(18): 2247 - 2255.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, and S. Vigili de Kreutzenberg
Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population
Stroke, September 1, 2006; 37(9): 2277 - 2282.
[Abstract] [Full Text] [PDF]